CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
GGGIX
Price
$61.81
Change
-$0.68 (-1.09%)
Updated
Jul 13 closing price
Net Assets
195.03M
Interact to see
Advertisement

CNPAX vs GGGIX

CNPAX vs GGGIX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. GGGIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and GGGIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. GGGIX (195M). CNPAX pays higher dividends than GGGIX: CNPAX (0.95) vs GGGIX (0.84). CNPAX was incepted earlier than GGGIX: CNPAX (24 years) vs GGGIX (19 years). GGGIX (1.22) is less costly to investors than CNPAX (0.74). CNPAX is a more actively managed with annual turnover of: 23.00 vs. GGGIX (15.00). CNPAX has a lower initial minimum investment than GGGIX: CNPAX (250) vs GGGIX (1000). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. GGGIX (-2.46). GGGIX return over 5 years is better than : 16.54 vs. CNPAX (13.82).
CNPAXGGGIXCNPAX / GGGIX
Total Expense Ratio0.740.9082%
Annual Report Gross Expense Ratio0.741.2261%
Fund Existence24 years19 years-
Gain YTD5.3254.744112%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets170B195M87,179%
Annual Yield % from dividends0.950.84114%
Returns for 1 year7.37-2.46-299%
Returns for 3 years34.1739.9985%
Returns for 5 years13.8216.5484%
Returns for 10 years115.91122.3995%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6